JAGX: Multiplikator rega marang pendapatan Jaguar Health Corp

Logo korporat perusahaan Jaguar Health Corp (JAGX)

Jaguar Health, Inc. (JAGX) enjoys deep trust among medical professionals due to its ethical approach to therapy. High patient loyalty is bolstered by the brand's pricing power within the HIV-associated diarrhea treatment niche. The company develops evidence-based botanical medicines, merging tropical flora with clinical practice. The current P/S multiple helps identify speculative valuation distortions, and the value of 0.20 shows the most recent reading of this indicator.

Multiplikator P/S: Jaguar Health, Inc. (JAGX) kanggo 04.07.2022 - 16.11.2026

Jaguar Health, Inc. (JAGX) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Analisis umum perusahaan:Jaguar Health, JAGX
Produk dadi Jaguar Health Corp

Jaguar Health, Inc. (JAGX) monetizes stable demand for plant-based drugs for the therapy of chemotherapy side effects, creating a sustainable revenue stream. An analysis of historical P/S dynamics, reflecting the ratio of the business's market value to annual turnover, allows for the determination of the asset's overbought status relative to average values and an assessment of how well the current price aligns with the fundamental value of this cash cow.